I. Olver

发表

Guideline update for MASCC and ESMO in the prevention of chemotherapy- and radiotherapy-induced nausea and vomiting: results of the Perugia consensus conference.

M. Kris, A. Horwich, C. Buske, 2010, Annals of oncology : official journal of the European Society for Medical Oncology.

2016 MASCC and ESMO guideline update for the prevention of chemotherapy- and radiotherapy-induced nausea and vomiting and of nausea and vomiting in advanced cancer patients.

E. Bruera, A. Molassiotis, M. Aapro, 2016, Annals of oncology : official journal of the European Society for Medical Oncology.

2016MASCC and ESMO guideline update for the prevention of chemotherapy- and radiotherapy-induced nausea and vomiting and of nausea and vomiting in advanced cancer patients

E. Bruera, A. Molassiotis, M. Aapro, 2016 .

Lorazepam: a randomized, double-blind, crossover study of a new antiemetic in patients receiving cytotoxic chemotherapy and prochlorperazine.

J. Matthews, I. Olver, M. Wolf, 1984, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Phase II trial of a 3-hour infusion of paclitaxel in previously untreated patients with advanced non-small-cell lung cancer.

M. Friedlander, D. Goldstein, M. Millward, 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Testosterone deficiency and quality of life in Australasian testicular cancer survivors: a prospective cohort study

M. Stockler, P. Grimison, I. Olver, 2014, Internal medicine journal.

A randomised double-blind study of high-dose intravenous prochlorperazine versus high-dose metoclopramide as antiemetics for cancer chemotherapy.

J. Matthews, I. Olver, M. Wolf, 1992, European journal of cancer.

Pharmacokinetics of trimetrexate administered by five-day continuous infusion to patients with advanced cancer.

D. Raghavan, R. Morris, I. Olver, 1987, Cancer research.

A randomised double blind crossover study of domperidone and prochlorperazine suppositories for controlling emesis in outpatients receiving chemotherapy.

J. Matthews, I. Olver, M. Wolf, 1994, European journal of cancer.

A randomized study of paclitaxel versus cyclophosphamide/methotrexate/5-fluorouracil/prednisone in previously untreated patients with advanced breast cancer: preliminary results. Taxol Investigational Trials Group, Australia/New Zealand.

D. Goldstein, M. Tattersall, S. Ackland, 1997, Seminars in Oncology.

Adriamycin combinations as salvage therapy in advanced MOPP-resistant Hodgkin's disease.

J. Matthews, I. Olver, M. Wolf, 1983, Australian and New Zealand journal of medicine.

Nitrogen mustard, vincristine, procarbazine, and prednisolone for relapse after radiation in hodgkin's disease. An analysis of long‐term follow‐up

J. Matthews, I. Olver, D. Cruickshank, 1988, Cancer.

Non-Hodgkin's lymphoma involving the central nervous system.

K. Liew, J. Madigan, I. Olver, 1985, Australian and New Zealand journal of medicine.

Aprepitant in antiemetic combinations to prevent chemotherapy‐induced nausea and vomiting

I. Olver, 2004, International journal of clinical practice.

Update on anti‐emetics for chemotherapy‐induced emesis

I. Olver, 2005, Internal medicine journal.

Carboplatin and continuous infusion 5-fluorouracil for advanced head and neck cancer.

D. Dalley, I. Olver, D. Cruickshank, 1989, European journal of cancer & clinical oncology.

Oral methotrexate for superficial transitional cell carcinoma of the bladder.

I. Olver, J. Bishop, A. Zimet, 1993, The Journal of urology.

Comparison of two standard chemotherapy regimens for good-prognosis germ-cell tumours: a randomised trial

M. Stockler, R. Simes, M. Jones, 2001, The Lancet.

Carboplatin (CBDCA, JM-8) and VP-16-213 in previously untreated patients with small-cell lung cancer.

R. Kefford, R. Stuart-Harris, D. Raghavan, 1987, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Concurrent radiotherapy and continuous ambulatory infusion 5-fluorouracil in advanced head and neck cancer.

K. Narayan, I. Olver, J. Smith, 1996, European journal of cancer.

Rifampicin as treatment for pruritus in malignant cholestasis

T. Price, I. Olver, W. Patterson, 1998, Supportive Care in Cancer.

Development of a murine gastric distension model for testing the emetic potential of new drugs and efficacy of antiemetics.

I. Olver, K. Thomas, B. Hillcoat, 1989, Chemico-biological interactions.

The roles of patient and observer assessments in anti-emetic trials.

J. Matthews, I. Olver, J. Bishop, 1994, European journal of cancer.

Symptomatic choroidal metastases in breast cancer.

I. Olver, J. Bishop, P. Jeal, 1992, Australian and New Zealand journal of medicine.

Effects of food-based interventions in the management of chemoradiotherapy-induced nausea and vomiting: a systematic review

A. Molassiotis, F. Scotté, I. Olver, 2023, Supportive Care in Cancer.